Thrombomodulin modulates cell migration in human melanoma cell lines.

Area of Science:

• Oncology
• Cell Biology
• Molecular Medicine

Background:

• Malignant melanoma exhibits altered growth factor expression compared to normal melanocytes.
• Thrombomodulin (TM) is an endothelial cell receptor that modulates thrombin activity.
• Reduced TM expression in tumors correlates with invasiveness and poor cancer prognosis.

Purpose of the Study:

• To evaluate thrombomodulin (TM) expression in human melanoma cell lines with varying aggressive phenotypes.
• To investigate the relationship between TM expression, cell migration, and interleukin-8 (IL-8) levels in melanoma.
• To determine if TM overexpression can reverse the aggressive phenotype of melanoma cells.

Main Methods:

• Quantitative real-time PCR (qPCR) to measure TM mRNA expression in melanoma cell lines (WM35, A375) and primary melanocytes.
• Assessment of in-vitro cell migration properties.
• Analysis of interleukin-8 (IL-8) expression levels.
• Transient transfection to overexpress TM in A375 melanoma cells.

Main Results:

• TM mRNA expression was significantly downregulated in both low (WM35) and high (A375) aggressive melanoma cell lines compared to normal melanocytes.
• Decreased TM expression inversely correlated with melanoma cell migration.
• High aggressiveness (A375) correlated with elevated interleukin-8 (IL-8) expression.
• Overexpression of TM in A375 cells reduced their aggressive phenotype and IL-8 expression.

Conclusions:

• Downregulation of thrombomodulin (TM) is a key factor in melanocyte transformation and melanoma progression.
• TM expression levels are inversely related to melanoma cell aggressiveness and migratory potential.
• Restoring TM expression may offer a therapeutic strategy to reverse melanoma's aggressive characteristics.